Literature DB >> 8669931

Bone mineral content in cystic fibrosis patients: correlation with fat-free mass.

F Salamoni1, M Roulet, F Gudinchet, M Pilet, D Thiébaud, P Burckhardt.   

Abstract

OBJECTIVE: To assess the bone mineral content in well nourished patients with cystic fibrosis and to seek a correlation with fat-free mass.
METHODS: Fourteen cystic fibrosis patients aged 6 to 20 years were studied and compared to 14 healthy controls matched for gender, age, and nutritional status. Bone mineral content was determined by dual energy x ray absorptiometry (DEXA).
RESULTS: Nutritional inquiry showed higher ingestion of macronutrients and micronutrients by cystic fibrosis patients than by controls. Mean whole skeleton bone mineral content was 1.184 (SD 0.536) kg in cystic fibrosis patients and 1.229 (0.576) kg in controls (p = 0.84). Mean lumbar spine bone mineral content was 0.031 (0.013) kg and 0.031 (0.016) kg, respectively (p = 0.99). Anthropometry, bioelectrical impedance analysis, and DEXA showed that fat-free mass was similar in the two groups. Bone mineral content was strongly correlated to fat-free mass. Mean blood calcium, phosphorus, serum 25-hydroxyvitamin D (25-OHD), parathyroid hormone (PTH), and osteocalcin were similar in both groups.
CONCLUSIONS: Bone mineral content and body composition are normal in a well nourished young cystic fibrosis population. Osteopenia previously reported in cystic fibrosis patients probably has nutritional origins and is therefore not related to a primary defect in bone mineral metabolism.

Entities:  

Mesh:

Year:  1996        PMID: 8669931      PMCID: PMC1511480          DOI: 10.1136/adc.74.4.314

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  27 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Assessment of total energy expenditure in free-living patients with cystic fibrosis.

Authors:  V Spicher; M Roulet; Y Schutz
Journal:  J Pediatr       Date:  1991-06       Impact factor: 4.406

3.  The systematic evaluation of the chest radiograph in cystic fibrosis.

Authors:  A R Chrispin; A P Norman
Journal:  Pediatr Radiol       Date:  1974

4.  Relative underweight in cystic fibrosis and its prognostic value.

Authors:  R Kraemer; A Rüdeberg; B Hadorn; E Rossi
Journal:  Acta Paediatr Scand       Date:  1978-01

5.  Performance of dual-energy x-ray absorptiometry in evaluating bone, lean body mass, and fat in pediatric subjects.

Authors:  G M Chan
Journal:  J Bone Miner Res       Date:  1992-04       Impact factor: 6.741

6.  Osteopenia in adults with cystic fibrosis.

Authors:  L K Bachrach; C W Loutit; R B Moss
Journal:  Am J Med       Date:  1994-01       Impact factor: 4.965

7.  Body composition analysis by dual-energy x-ray absorptiometry in adults with cystic fibrosis.

Authors:  T Rochat; D O Slosman; C Pichard; D C Belli
Journal:  Chest       Date:  1994-09       Impact factor: 9.410

8.  Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence.

Authors:  J P Bonjour; G Theintz; B Buchs; D Slosman; R Rizzoli
Journal:  J Clin Endocrinol Metab       Date:  1991-09       Impact factor: 5.958

9.  The changing epidemiology of cystic fibrosis.

Authors:  S C FitzSimmons
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

10.  Bio-electrical impedance analysis for estimation of fat-free mass and muscle mass in cystic fibrosis patients.

Authors:  V Spicher; M Roulet; C Schaffner; Y Schutz
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

View more
  12 in total

1.  Correlates of prepubertal bone mineral density in cystic fibrosis.

Authors:  R H Haslam; D J Borovnicar; D B Stroud; B J Strauss; J E Bines
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

2.  Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis.

Authors:  H M Buntain; P J Schluter; S C Bell; R M Greer; J C H Wong; J Batch; P Lewindon; C E Wainwright
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

3.  Well-nourished cystic fibrosis patients have normal mineral density, but reduced cortical thickness at the forearm.

Authors:  O Louis; P Clerinx; I Gies; E De Wachter; J De Schepper
Journal:  Osteoporos Int       Date:  2008-06-07       Impact factor: 4.507

4.  Bone mineral status in 134 patients with cystic fibrosis.

Authors:  E M Laursen; C Molgaard; K F Michaelsen; C Koch; J Müller
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

5.  Normal bone mineral density in cystic fibrosis.

Authors:  D S Hardin; R Arumugam; D K Seilheimer; A LeBlanc; K J Ellis
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

6.  Bone mineral and body composition alterations in paediatric cystic fibrosis patients.

Authors:  Philippe Reix; Gabriel Bellon; Pierre Braillon
Journal:  Pediatr Radiol       Date:  2009-12-03

7.  Vitamin d deficiency in cystic fibrosis.

Authors:  William B Hall; Amy A Sparks; Robert M Aris
Journal:  Int J Endocrinol       Date:  2010-01-28       Impact factor: 3.257

8.  Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study.

Authors:  H M Buntain; R M Greer; P J Schluter; J C H Wong; J A Batch; J M Potter; P J Lewindon; E Powell; C E Wainwright; S C Bell
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

9.  Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.

Authors:  C M Gordon; E Binello; M S LeBoff; M E Wohl; C J Rosen; A A Colin
Journal:  Osteoporos Int       Date:  2006-03-16       Impact factor: 4.507

10.  Bone and body composition analyzed by Dual-energy X-ray Absorptiometry (DXA) in clinical and nutritional evaluation of young patients with Cystic Fibrosis: a cross-sectional study.

Authors:  Vincenzina Lucidi; Carla Bizzarri; Federico Alghisi; Sergio Bella; Beatrice Russo; Graziamaria Ubertini; Marco Cappa
Journal:  BMC Pediatr       Date:  2009-09-28       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.